Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 5.91Yasons Chemex Care Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates strong solvency and notable growth in revenue and operating profit. Profitability metrics, particularly gross profit and operating margins, are also robust. However, liquidity is weak, and certain efficiency and financial metrics indicate areas needing attention. While the company shows promise in revenue and profit growth, inconsistent earnings per share and net income growth, coupled with low coverage ratios and returns on equity and assets, present challenges. Overall, the company's strengths in solvency, revenue, and operating profit growth are somewhat offset by liquidity issues and inconsistent profitability and efficiency metrics. Future performance will likely depend on addressing these inconsistencies and leveraging its growth potential effectively.
Health Score : 5.91Yasons Chemex Care Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates strong solvency and notable growth in revenue and operating profit. Profitability metrics, particularly gross profit and operating margins, are also robust. However, liquidity is weak, and certain efficiency and financial metrics indicate areas needing attention. While the company shows promise in revenue and profit growth, inconsistent earnings per share and net income growth, coupled with low coverage ratios and returns on equity and assets, present challenges. Overall, the company's strengths in solvency, revenue, and operating profit growth are somewhat offset by liquidity issues and inconsistent profitability and efficiency metrics. Future performance will likely depend on addressing these inconsistencies and leveraging its growth potential effectively.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
22.14
Industry Median
33.49
Small Cap Median
27.15
P/E RATIO
22.14
P/B RATIO
0.50
Industry Median
2.48
Small Cap Median
2.37
P/S RATIO
0.22
Industry Median
2.35
Small Cap Median
1.71
Others
PEG RATIO
0.00
EV/EBITDA RATIO
6.17
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹10.85 as on Jul 11, 2026.
Growth Score : 6.00The company's growth ratio indicates very strong performance in revenue and operating profit, but lower performance in EPS and net income growth. The strong growth in revenue and operating profit could be promising, but the company needs to focus on translating this growth into improved earnings per share and net income.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 0 | 88.31 | 10.53 | 26.51 | |
| Operating Profit Growth Rate | 0 | 430.61 | -51.15 | -146.46 | |
| Earnings Per Share (EPS) Growth | -58.35 | -73.14 | 29.23 | -41.67 | |
| Asset Growth Rate | 97.86 | 8.68 | 14.5 | ||
| Net Income Growth Rate | 0 | -63.56 | 29.6 | -41.98 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Saroja Pharma Industries India Ltd | 7.47 | 13.67 | Neutral | 3.81 | 4.02 | 1.62 |
| 2 | Sanginita Chemicals Ltd | 7.17 | 62.58 | Undervalued | -6.00 | -3.74 | -10.00 |
| 3 | Yasons Chemex Care Ltd | 5.91 | 22.14 | Neutral | -0.59 | 0.49 | 0.94 |
| 4 | Vadivarhe Speciality Chemicals Ltd | 4.07 | -3.66 | Highly Undervalued | -6.42 | -7.25 | -9.27 |
| 5 | Omkar Speciality Chemicals Ltd | 3.63 | 0.23 | Highly Undervalued | 101.00 | -128.49 | 37.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Cash Earnings Per Share (Cash EPS)